FDA Risk Communication Advisory Committee Discusses Consumer Information

The FDA Risk Communication Advisory Committee met on February 26-27, 2009 and discussed the history, development, and adequacy of Medication Guides, Patient Package Inserts, and Consumer Medical Information as information resources for patient populations, and concluded with a strong endorsement for using behavioral and social science in the design and evaluation of FDA communications.
On February 26-27, the Food and Drug Administration held a meeting of the Risk Communication Advisory Committee. The meeting focused on discussing the history, development, and adequacy of Medication Guides, Patient Package Inserts, and Consumer Medical Information as information resources for patient populations. APA Fellow Dr. Baruch Fischhoff, who chairs the Committee, began the meeting by reviewing a series of questions to be discussed across two days of presentations.  The end result was a detailed set of recommendations that concluded with a strong endorsement for using behavioral and social science in the design and evaluation of FDA communications.  These recommendations have been sent to FDA’s senior leadership for consideration and action.